İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2002 · article

Risk Factors for Late Onset Nosocomial Pneumonia Caused byStenotrophomonas maltophilia in Critically Ill Trauma Patients

ISSN1058-4838
YÖKSİS OpenAlex Açık erişim · bronze SJR Q1 JCR Q1 Üst %10
Yıl2002
Atıf142OpenAlex
Yüzdelik%97,4
FWCI6,561,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q1

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıClinical Infectious Diseases
  • Katalog eşleşmesi (ISSN)Clinical Infectious Diseases
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

OpenAlex İngilizce

Patients with nosocomial pneumonia caused by Stenotrophomonas maltophilia often receive inadequate empiric antibiotic therapy, potentially increasing mortality. Knowledge of the risk factors associated with S. maltophilia pneumonia may better guide the selection of empiric antibiotic therapy. Potential risk factors for S. maltophilia pneumonia were retrospectively analyzed for critically ill trauma patients with late-onset gram-negative pneumonia. The effects of S. maltophilia infection and inadequate empiric antibiotic therapy on patient outcomes were also assessed. By multivariate analysis, S. maltophilia pneumonia was found to be associated with cefepime exposure and tracheostomy in patients with a single pneumonia episode and with higher Injury Severity Score and pulmonary contusion in patients with multiple pneumonia episodes. S. maltophilia pneumonia was associated with increased patient morbidity; only inadequate empiric antibiotic therapy was associated with a higher mortality rate. In critically ill trauma patients with late-onset ventilator-associated pneumonia and these risk factors, empiric antibiotic therapy should include agents active against S. maltophilia.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

142atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 18 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2016 Is prolonged infusion of piperacillin tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic pharmacodynamic and patient outcomes An observation from the Defining Antibiotic Levels in Intensive care unit patients DALI cohortAtıf 168 · OpenAlex
  2. 2004 Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogenAtıf 156 · OpenAlex
  3. 2006 Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia An analysis of associated risk factors in a tertiary care hospitalAtıf 53 · OpenAlex
  4. 2006 Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia An analysis of associated risk factors in a tertiary care hospitalAtıf 53 · OpenAlex
  5. 2005 Stenotrophomonas maltophilia antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospitalAtıf 52 · OpenAlex
  6. 2011 Risk factors and clinical characteristics of Stenotrophomonas maltophilia infections in neonatesAtıf 44 · OpenAlex
  7. 2011 Risk factors and clinical characteristics of Stenotrophomonas maltophilia infections in neonatesAtıf 44 · OpenAlex
  8. 2009 Chemical composition antimicrobial and antioxidant activities of Centaurea ensiformis Hub Mor Asteraceae a species endemic to Mugla TurkeyAtıf 36 · OpenAlex
  9. 2009 Chemical Composition Antimicrobial and Antioxidant Activities of Centaurea ensiformis Hub Mor Asteraceae An Endemic Species to Mugla TurkeyAtıf 36 · OpenAlex
  10. 2009 Chemical composition antimicrobial and antioxidant activities of Centaurea ensiformis Hub Mor Asteraceae an endemic species to Mugla TurkeyAtıf 36 · OpenAlex

Yazarlar

7
  1. Hanes Scott D 1
  2. SALİH KUTAY DEMİRKAN HACETTEPE ÜNİVERSİTESİ 2
  3. Tolley Elizabeth 3
  4. Boucher Bradley A 4
  5. Croce Martin A 5
  6. Wood G Christopher 6
  7. Fabian Timothy C 7